Home > Products > UV-Curing Materials > Photoinitiators > Brexpiprazole CAS 913611-97-9

Brexpiprazole CAS 913611-97-9

    Payment Type: L/C,T/T,D/P,Paypal,Money Gram,Western Union
    Incoterm: FOB,CFR,CIF,EXW,FCA,CPT,CIP
    Min. Order: 10 Gram

Basic Info

Model No.TF-3476

BrandTianfu

Additional Info

PackagingAs Buyer's Request

Productivity100Ton

TransportationOcean,Land,Air,DHL,TNT

Place of OriginChina

Supply Ability50Ton

CertificateISO

PortShanghai port,Qingdao port

Payment TypeL/C,T/T,D/P,Paypal,Money Gram,Western Union

IncotermFOB,CFR,CIF,EXW,FCA,CPT,CIP

Product Description

Product Name: Brexpiprazole
Synonyms: Brexpiprazole(OPC34712);7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one;Brexpiprazole;OPC-34712;7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]- 2(1H)-Quinolinone;7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one;7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one;Brexpiprazole impurity a
CAS: 913611-97-9
MF: C25H27N3O2S
MW: 433.57
EINECS: 811-628-7
Product Categories: Inhibitors;Dopamine D2 receptor partial agonist;-;API
Mol File: 913611-97-9.mol
Brexpiprazole Structure
Brexpiprazole Chemical Properties
Safety Information
MSDS Information
Brexpiprazole Usage And Synthesis
Description Brexpiprazole is a kind of atypical antipsychotic. It is a dopamine D2 receptor partial agonist. As a novel serotonin-dopamine activity modulator, it can be used for the treatment of schizophrenia, and for the adjunctive treatment for depression. It can also provide efficacy and tolerability over established adjunctive treatments formajor depressive disorder(MDD).Recent study has also suggested it can ameliorate PCP-induced cognitive deficits in mice via 5-HT1A receptors.
References https://en.wikipedia.org/wiki/Brexpiprazole
https://www.drugbank.ca/drugs/DB09128
Maeda, K, et al. "Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator." Journal of Pharmacology & Experimental Therapeutics 350.3(2014):589-604.
Maeda, K, et al. "Brexpiprazole II: antipsychotic-like and procognitive effects of a novel serotonin-dopamine activity modulator." Journal of Pharmacology & Experimental Therapeutics 350.3(2014):605.
Yoshimi, N, et al. "Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: a role for serotonin 5-HT1A receptors. " Pharmacology Biochemistry & Behavior 124(2014):245.

Product Categories : UV-Curing Materials > Photoinitiators

Product Images

  • Brexpiprazole CAS 913611-97-9
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Communicate with Supplier?Supplier
Anson Mr. Anson
What can I do for you?
Contact Supplier